Reduction of the nitro group to amine by hydroiodic acid to synthesize o-aminophenol derivatives as putative degradative markers of neuromelanin

Molecules

Volumn 19, Issue 6, 2014, Pages 8039-8050

  Wakamatsu, Kazumasa ^a   Tanaka, Hitomi ^a   Tabuchi, Keisuke ^a   Ojika, Makoto ^b   Zucca, Fabio A ^c   Zecca, Luigi ^c   Ito, Shosuke ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c CNR   (Italy)

Author keywords

Aminohydroxyethylbenzene; Aminohydroxyphenylacetic acid; Aminohydroxyphenylethylamine; HI reduction; Neuromelanin; Parkinson's disease

Indexed keywords

2-AMINOPHENOL; 3,4 DIHYDROXYPHENYLACETIC ACID; 3,4-DIHYDROXYPHENYLETHANOL; ACID; AMINOPHENOL DERIVATIVE; HYDROIODIC ACID; IODINE DERIVATIVE; MELANIN; NEUROMELANIN; PHENETHYL ALCOHOL;

ANALOGS AND DERIVATIVES; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCUS CERULEUS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ACIDS; AMINOPHENOLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; IODINE COMPOUNDS; LOCUS COERULEUS; MAGNETIC RESONANCE SPECTROSCOPY; MELANINS; PHENYLETHYL ALCOHOL; SUBSTANTIA NIGRA;

EID: 84903286824     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19068039     Document Type: Article

References (28)

1. Ito S.; Wakamatsu K. Quantitative analysis of eumelanin and pheomelanin in humans mice and other animals: A comparative review. Pigment Cell Res. 2003 16 523-531.
2. Ito S.; Wakamatsu K. Chemistry of melanins. In The Pigmentary System. Physiology and Pathophysiology 2nd ed.; Nordlund J.J. Boissy R.E. Hearing V.J. King R.A. Oetting W.S. Ortonne J.P. Eds.; Blackwell Publishing: Oxford UK 2006 ; pp. 282-310.
3. Simon J.D.; Peles D.N. The red and the black. Acc. Chem. Res. 2010 43 1452-1460.
4. Marsden C.D. Pigmentation in the nucleus substantiae nigrae of mammals. J. Anat. 1961 95 256-261.
5. Zucca F.A.; Basso E.; Cupaioli F.A.; Ferrari E.; Sulzer D.; Casella L.; Zecca L. Neuromelanin of the human substantia nigra: An update. Neu rotox. Res. 2013 25 13-23.
6. Wakamatsu K.; Fujikawa K.; Zucca L.; Zecca L.; Ito S. The structure of neuromelanin as studied by chemical degradative methods. J. Neurochem. 2003 86 1015-1023.
7. Wakamatsu K.; Murase T.; Zucca F.A.; Zecca L.; Ito S. Biosynthetic pathway to neuromelanin and its aging process. Pigment Cell Melanoma Res. 2012 25 792-803.
8. Zecca L.; Costi P.; Mecacci C.; Ito S.; Terreni M.; Sonnino S. Interaction of human substantia nigra neuromelanin with lipids and peptides. J. Neurochem. 2000 74 1758-1765.
9. Zecca L.; Stroppolo A.; Gatti A.; Tampellini D.; Toscani M.; Gallorini M.; Giaveri G.; Arosio P.; Santambrogio P.; Fariello R.G.; et al. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc. Natl. Acad. Sci. USA 2004 101 9843-9848.
10. Zecca L. Bellei C. Costi P. Albertini A. Monzani E. Casella L. Gallorini M. Bergamaschi L. Moscatelli A. Turro N.J. et al New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals. Proc. Natl. Acad. Sci. USA 2008 1 05 17567-17572.
11. Langston J.W.; Forno L.S.; Tetrud J.; Reeves A.G.; Kaplan J.A.; Karluk D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-p henyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 1999 46 598-605.
12. McGeer P.L.; Itagaki S.; Boyes B.E.; McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988 38 1285-1291.
13. Zecca L.; Wilms H.; Geick S.; Claasen J.H.; Brandenburg L.O.; Holzknecht C.; Panizza M.L.; Zucca F.A.; Deuschl G.; Sievers J.; et al. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: Implications for Parkinson's disease. Acta Neuropathol. 2008 116 47-55.
14. Zhang W.; Phillips K.; Wielgus A.R.; Liu J.; Albertini A.; Zucca F.A.; Faust R.; Qian S.Y.; Miller D.S.; Chignell C.F.; et al. Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: Implications for progression o f Parkinson's disease. Neurotox. Res. 2011 19 63-72.
15. Cebriá n C.; Zucca F.A.; Mauri P.; Steinbeck J.A.; Studer L.; Scherzer C.R.; Kanter E.; Budhu S.; Mandelbaum J.; V onsattel J.P.; et al. MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nat. Commun. 2014 5 3633.
16. Ito S.; Fujita K. Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography. Anal. Biochem. 1985 144 527-536.
17. Ito S.; Wakamatsu K. Chemical degradation of melanins: Application to identification of dopamine-melanin. Pigment Cell Res. 1998 11 120-126.
18. Wakamatsu K.; Ito S.; Rees J.L. Usefulness of 4-amino-3- hydroxyphenylalanine as a specific marker of pheomelanin. Pigment Cell Res. 2002 15 225-232.
19. Ito S.; Nakanishi Y.; Valenzuela R.K.; Brilliant M.H.; Kolbe L.; Wakamatsu K. Usefulness of alkaline hydrogen peroxide oxidation to analyze eumelanin and pheomelanin in various tissue samples: Application to chemical analysis of human hair melanins. Pigment Cell Melanoma Res. 2011 24 605-613.
20. d'Ischia M.; Wakamatsu K.; Napolitano A.; Briganti S.; Garc ia-Borron J.-C.; Kovacs D.; Meredith P.; Pezzella A.; Picardo M.; Sarna T.; et al. Melanins and melanogenesis: Methods standards protocols. Pigment Cell Melanoma Res. 2013 26 616-633.
21. Wakamatsu K.; Ohtara K.; Ito S. Chemical analysis of late stages of phaeomelanogenesis: Conversion of dihydrobenzothiazine to a benzothiazole structure. Pigment Cell Melanoma Res. 2009 22 474-486.
22. Ito S.; Fujita K.; Yoshioka M.; Sienko D.; Nagatsu T. Identification of 5-S-and 2-S-cysteinyldopamine and 5-S-glutathionyldopamine formed from dopamine by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. Biomed. Appl. 1986 375 134-140.
23. Ito S.; Kato T.; Fujita K. Covalent binding of catechols to proteins through the sulphydryl group. Biochem. Pharmacol. 1988 37 1707-1710.
24. Cartolano A.R.; Vedage G.A. Amines by reduction. In Kirk-Othmer Encyclopedia of Chemical Technology; John Wiley & Sons Inc: Hoboken NJ USA 2004; doi:10.1002/0471238961.0113091419030809.a01.pub2.
25. Scheme B.G.R. Bé champ Reduction. In Comprehensive Organic Name Reactions and Reagents; John Wiley & Sons Inc: Hoboken NJ USA 2010; pp. 284-287.
26. Sajiki H.; Hattori K.; Hirota K. The formation of a novel Pd/C-ethylenediamine complex catalyst: Chemoselective hydrogenation without deprotection of the O-benzyl and N-Cbz groups. J. Org. Chem. 1998 63 7990-7992.
27. Shafiee A .; Parang K.; Khaza M.; Ghasemian F. Nitroimidazoles X. Syntheses of substituted 2-(1-methyl-5-nitro-2-imidazolyl) quinolines. J. Heterocycl. Chem. 2009 29 1859-1861.
28. Engelen M.; Vanna R.; Bellei C.; Zucca F.A.; Wakamatsu K.; Monzani E.; Ito S.; Casella L.; Zecca L. Neuromelanins of human brain have soluble and insoluble components with dolichols attached to the melanic structure. PLoS One 2012 7 e48490.